LAUSR

About LAUSR
Donate
Contact Us

Follow us:

You are not signed in:

Sign Up!


   Articles with "baseline ldl" as a keyword



Photo from wikipedia

Cost-effectiveness of statin therapy for secondary prevention among patients with coronary artery disease and baseline LDL-C 70-100 mg/dL in Taiwan.

Sign Up to like & get
recommendations! Published in 2020 at "Journal of the Formosan Medical Association = Taiwan yi zhi"

DOI: 10.1016/j.jfma.2020.01.010

Abstract: BACKGROUND The recommended target low-density lipoprotein cholesterol (LDL-C) level for coronary artery disease (CAD) patients has been lowered from 100 to 70 mg/dL in several clinical guidelines for secondary prevention. We aimed to assess whether initiating… read more here.

Keywords: baseline ldl; coronary artery; taiwan; cad patients ... See more keywords

The journey to LDL-C goal in the era of combination lipid lowering therapy and why it matters for ASCVD patients: a UK perspective

Sign Up to like & get
recommendations! Published in 2024 at "Current Medical Research and Opinion"

DOI: 10.1080/03007995.2024.2400273

Abstract: Abstract Objective We aim to explore the concept of distance and journey to goal, and consideration of these 2 elements a priori when choosing LLT. Methods Modelling of expected % LDL-C reductions was carried out… read more here.

Keywords: ldl goal; ldl; goal; journey ldl ... See more keywords
Photo from wikipedia

REDUCE-IT: total ischemic events reduced across the full range of baseline LDL cholesterol and other key subgroups

Sign Up to like & get
recommendations! Published in 2020 at "European Heart Journal"

DOI: 10.1093/ehjci/ehaa946.3011

Abstract: REDUCE-IT (Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial), a study of 8,179 randomized statin-treated patients with elevated triglycerides (TG) and increased cardiovascular (CV) risk followed for a median of 4.9 years, demonstrated robust results.… read more here.

Keywords: baseline ldl; endpoint; key secondary; baseline ... See more keywords

Apolipoprotein A-I Infusions and Cardiovascular Outcomes in Acute Myocardial Infarction According to Baseline LDL-Cholesterol Levels: The AEGIS-II Trial.

Sign Up to like & get
recommendations! Published in 2024 at "European heart journal"

DOI: 10.1093/eurheartj/ehae614

Abstract: BACKGROUND AND AIMS In the AEGIS-II trial (NCT03473223), CSL112, a human apolipoprotein A1 derived from plasma that increases cholesterol efflux capacity, did not significantly reduce the risk of the primary endpoint through 90 days versus… read more here.

Keywords: csl112; baseline ldl; risk; aegis trial ... See more keywords

Effects of Alirocumab and Evolocumab on Cardiovascular Mortality and LDL-C: Stratified According to the Baseline LDL-C Levels

Sign Up to like & get
recommendations! Published in 2025 at "Reviews in Cardiovascular Medicine"

DOI: 10.31083/rcm26980

Abstract: Background: A meta-analysis was conducted to determine whether the cardiovascular mortality and lipid-lowering effects of alirocumab and evolocumab are influenced by various baseline low-density lipoprotein cholesterol (LDL-C) levels. Methods: We searched for literature published before… read more here.

Keywords: ldl levels; ldl; baseline; cardiovascular mortality ... See more keywords